DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DongKoo Bio & Pharma Co Ltd
KOSDAQ:006620
|
KR |
|
X
|
Xinjiang LaChapelle Fashion Co Ltd
HKEX:6116
|
CN |
|
E
|
EnSilica PLC
LSE:ENSI
|
UK |
|
Lotus Resources Ltd
OTC:LTSRF
|
AU |
|
Diploma PLC
LSE:DPLM
|
UK |
|
M
|
MSM Malaysia Holdings Bhd
KLSE:MSM
|
MY |
|
Johnson Electric Holdings Ltd
HKEX:179
|
HK |
|
Af Gruppen ASA
OSE:AFG
|
NO |
|
T
|
Trigiant Group Ltd
HKEX:1300
|
CN |
|
CIELO SA Instituicao de Pagamento
F:28MA
|
BR |
|
C
|
Complete Solaria Inc
NASDAQ:CSLR
|
US |
|
Altisource Portfolio Solutions SA
NASDAQ:ASPS
|
LU |
|
P
|
PGT Innovations Inc
F:P9I
|
US |
|
I
|
Icade SA
OTC:CDMGF
|
FR |
|
A
|
Andira Agro Tbk PT
IDX:ANDI
|
ID |
|
Tesserent Ltd
ASX:TNT
|
AU |
|
Trans Global Group Inc
OTC:TGGI
|
US |
|
H
|
Harvia Oyj
OMXH:HARVIA
|
FI |
|
S
|
Skyline Builders Group Holding Ltd
NASDAQ:SKBL
|
HK |
|
Apple Inc
NASDAQ:AAPL
|
US |
|
S
|
Santander Consumer USA Holdings Inc
F:77S
|
US |
|
G
|
Genfit SA
PAR:GNFT
|
FR |
DongKoo Bio & Pharma Co Ltd
DongKoo Bio & Pharm Co. Ltd. operates as a holding company engaged in the manufacture and sale of pharmaceutical products and health supplements. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-02-13. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The major products include antihistamines, topical steroids, therapeutic agents for prostatitis, treatments for benign prostatic hyperplasia, atherosclerotic agents, and antibiotics, among others. The firm is involved in contract manufacturing organization business. The company manufactures and sells therapeutic for osteoporosis, antiviral agents, erectile dysfunction treatments, hepatic disease agents; painkillers; gum treatments. In addition, the Company is engaged in the manufacturing and sale of medical devices and cosmetics. The firm distributes its products within the domestic market and to overseas markets, including America and Europe.
DongKoo Bio & Pharm Co. Ltd. operates as a holding company engaged in the manufacture and sale of pharmaceutical products and health supplements. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-02-13. is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The major products include antihistamines, topical steroids, therapeutic agents for prostatitis, treatments for benign prostatic hyperplasia, atherosclerotic agents, and antibiotics, among others. The firm is involved in contract manufacturing organization business. The company manufactures and sells therapeutic for osteoporosis, antiviral agents, erectile dysfunction treatments, hepatic disease agents; painkillers; gum treatments. In addition, the Company is engaged in the manufacturing and sale of medical devices and cosmetics. The firm distributes its products within the domestic market and to overseas markets, including America and Europe.
